H.R. 2064
IntroducedTo amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Introduced 4/3/2019•116th Congress•House
Latest Action
Subcommittee Hearings Held.
5/21/2019 • House
Summary
This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.
Introduced in House • 4/3/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Consumer affairsGovernment information and archivesHealth technology, devices, suppliesInflation and pricesPrescription drugs
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
R[
Bill Journey
Originated in the House
Introduced
April 3, 2019
Committee Review
May 21, 2019
Subcommittee Hearings Held.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House4/3/2019